نتائج البحث

Safety and Efficacy Study of ISIS 301012 (Mipomersen) Administration in High Risk Statin Intolerant Subjects (ASSIST)

• Authors : Ionis Pharmaceuticals, Inc.

• Source: A Randomized, Double-Blind, Placebo-Controlled Study to Assess Safety and Efficacy of ISIS 301012 Administration in High Risk Statin Intolerant SubjectsVisser ME, Wagener G, Baker BF, Geary RS,

تفاصيل العنوان